Asston Pharmaceuticals Ltd

BSE: 544445 · Pharmaceuticals & Biotechnology · 21 announcements

Share price: ₹98.15
Market cap: ₹83.55 Cr
Revenue (annual): ₹25.47 Cr
Net profit (annual): ₹3.87 Cr
P/E (TTM): 21.6×Sector 47.4×
Promoter holding: 50.66%
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 8 Board Meeting Date 3 Other Announcement 2 Financial Results 2 Capital Structure Change 2 Fund Raise 1 Debt & Borrowing 1 Board Meeting Outcome 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

30 Apr 2026 22:00 IST BSE

Debt & Borrowing

Asston Pharmaceuticals Debt & Borrowing: ₹5.04 Cr

Asston Pharmaceuticals Limited confirmed it is not classified as a Large Corporate under SEBI framework for the financial year. The company reported outstanding borrowings of ₹5.04 Crore as of March 31, 2024. This disclosure ensures regulatory compliance regarding debt-raising requirements for listed entities.

Value: ₹5.04 Cr

Read the filing ↗